6533b7defe1ef96bd1275c52
RESEARCH PRODUCT
Relationship between endocrine disruptors and obesity with a focus on bisphenol A: a narrative review
Malha OudirAissam BousbiaSofiane BoudaliaBoualem BoumaazaMarie Chantal Canivenc Laviersubject
Medicine (General)obesityFuture studiesQH301-705.5bisphenol APharmaceutical Science030209 endocrinology & metabolismReviewBiologyBioinformaticsadipocyteGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciences0302 clinical medicineR5-920medicineEndocrine systemmetabolic disordersEpigeneticsBiology (General)030304 developmental biology0303 health sciencesfat tissuesLow doseGeneral Medicine[SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciencesmedicine.diseaseObesity3. Good healthperoxisome proliferator-activated receptor-γNarrative reviewdescription
International audience; Introduction: Scientific data suggest that early exposure to endocrine-disrupting chemicals (EDCs) affect -repro, -neuro, -metabolic systems, to which are added other notions such as mixtures, window and duration of exposure, trans-generational effects, and epigenetic mechanisms. Methods: In the present narrative review, we studied the relationship between exposure to EDCs with the appearance and development of obesity. Results: Exposure to EDCs like Bisphenol A during the early stages of development has been shown to lead to weight gain and obesity. EDCs can interfere with endocrine signaling, affect adipocytes differentiation and endocrine function and disrupt metabolic processes, especially if exposure occurs at very low doses, in the mixture, during early development stages for several generations. Conclusion: Exposure to EDCs is positively associated with obesity development. Moreover, the use of integrative approaches which mimicking environmental conditions are necessary and recommended to evaluate EDCs' effects in future studies.
year | journal | country | edition | language |
---|---|---|---|---|
2021-01-01 |